@drrickbarnett @maiasz Vivitrol or naltrexone should not be classed with agonists or partial agonists. May work for a few, often coercive. It offers no protection should people stop & reinitiate- it increases risk with super sensitisation https://t.co/
@borousk @DrewTurner73 @US_FDA Nobody said it was while actually on it, so you’ll be waiting a while. https://t.co/sp47KxgdiM
@maiasz @D_Winetsky_MD Absolutely. Even the existing reports indicate the potentiation problem is under-appreciated https://t.co/drPIteFOkC
@howell_ben @TruMedicines Not the only medication approved by the FDA but where questions about effectiveness persist. FDA approval process can and is gamed. This is why we have to double (triple, quadruple) down on post-marketing surveillance see also h
RT @LarochelleMarc: @LeoBeletsky @JonGiftosMD @Recovery_ABrown @maiasz @tmarshallmph @drrickbarnett Reasons to be concerned, need more data…
@LeoBeletsky @JonGiftosMD @Recovery_ABrown @maiasz @tmarshallmph @drrickbarnett Reasons to be concerned, need more data. Here is a thread where I discuss naltrexone findings from our paper of MOUD after NFOD; https://t.co/wZpdgevvZ9. Also see this case nar
"Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence" - https://t.co/YPDHXnk73M -- Vivitrol being promoted as MAT in jails ~ @NDEWSNews
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @sanoysalvoblog: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence Adverse even…
RT @sanoysalvoblog: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence Adverse even…
Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence Adverse event reports suggest the need to investigate 2 months following the last injection as a period of particular concern for overdose https://t.
Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence Adverse event reports suggest the need to investigate 2 months following the last injection as a period of particular concern for overdose https://t.
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @himmoderator: It may be that in years to come people working in the treatment of #opioid use disorder will look back at the use of #nal…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
Rebound risk for opioid overdose in patients coming off oral natrexone #opioid overdose #drugsafety #pharmacovigilance https://t.co/ZiVDVUmNNK https://t.co/PMJjdSSZvk
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
@maiasz I see George Soros Open Society is behind this VIVITROL study. Ask George to be a love-file FOIA @SGottliebFDA to get stats on how many suboxone pts have overdosed & how many are still alive shooting & snorting the suboxone they don't sell
@AlexWodak let's get something clear- When you #overdose with on buprenorphine suboxone (which ME barely tests for) with 3 other drugs in your system it's the coke or benzo cause of death but when you OD while on VIVTROL & 3 other drugs in your system
@AlexWodak are you freaking kidding me? How long has @andrewkolodny @maiasz @LeoBeletsky @SGottliebFDA @ASAMorg @samhsagov @CDCDirector known addicted are injecting & snorting their suboxone they don't sell for heroin cuz the Naloxone ingredient is bul
RT @OpioidPolicyBTV: https://t.co/l15lKK8e6k Worth the read...
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @maiasz: this was one of the key concerns that spurred this reporting https://t.co/FAKVpg7EVf https://t.co/UgdPj7ir5y
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @alissasadler: New study highlights need to track overdose deaths of patients taking or who have recently taken #Vivitrol, and for cauti…
New study highlights need to track overdose deaths of patients taking or who have recently taken #Vivitrol, and for caution when prescribing--especially to people in the criminal justice system or others who may not be able to commit to treatment: https://
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
@ADAWnews Might want to reconsider the narrow choice of MAT... the drug maker has been sitting on 52 reports of overdose death with Vivitrol, and not following up on 67 more deaths, according to newly liberated FDA data. https://t.co/0dUfXCi2mp
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
We are prescribing #Vivitrol to address opioids—but are following what happens when patients stop? New study in Drug Safety looks at FDA adverse events reports, finds overdose fatalities greatest in two months after stopping: https://t.co/vRJsubSDwe @wolf
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @wolfenyc: We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at…
RT @ADAWnews: "We also urge greater scrutiny of sponsor claims of no connection between Vivitrol and overdose in the case narratives....the…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
We are prescribing Vivitrol for opioids--but are we gauging overdose dangers rightly? Our new study in Drug Safety looks at FDA reports & finds fatalities and important questions about what drugmakers keep quiet. https://t.co/dykgAxprX8 @nabarund #nal
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
It may be that in years to come people working in the treatment of #opioid use disorder will look back at the use of #naltrexone and wonder: "What were they *thinking*?" https://t.co/GIJG5Xm2bs
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
RT @AlexWodak: Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wol…
Very important new paper just out. Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Saucier, Wolfe, Dasgupta; Drug Safety; Free access: https://t.co/QcCPNVzzNA How long have company, researchers, NIDA known this?
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @maiasz: this was one of the key concerns that spurred this reporting https://t.co/FAKVpg7EVf https://t.co/UgdPj7ir5y
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @maiasz: this was one of the key concerns that spurred this reporting https://t.co/FAKVpg7EVf https://t.co/UgdPj7ir5y
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…